Evolvability, observed

The most successful E. coli strains in a long-term evolution experiment were those that showed the greatest potential for adaptation

Written byJef Akst
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
Natural selection picks the most well adapted organisms to survive and reproduce. But what if the most beneficial mutations in the short term meant less room for adaptation in the future?
Petri dishes containing colonies of E. coli
Image: Brian Baer
New research suggests that the capacity of a species to further adapt to its environment, or evolvability, can be just as important, or more so, than the adaptations it's already acquired. The results, published this week in Science, give an empirical foundation to a theory that, in addition to beneficial mutations that confer immediate fitness advantages, long-term evolvability may be important for determining a species' success."[The idea of] selection for evolvability has been in the air for a long time, but this is one of the first real systematic and explicit demonstrations of this actually happening," said evolutionary biologist and population geneticist linkurl:Michael Desai;http://www.oeb.harvard.edu/faculty/desai/desai-oeb.html of Harvard University, who was not involved in the study.Researchers at Michigan State University and the University of Houston in Texas took advantage of a long-term evolution experiment on Escherichia coli that's been running for more than 50,000 generations. Characterizing archived strains from 500, 1000, and 1500 generations, the team identified two beneficial mutations that arose in some strains prior to 500 generations and eventually spread through the entire population. The researchers dubbed the strains that carried these mutations at 500 generations the eventual winners (EWs) and those lacking the mutations the eventual losers (ELs).The first surprise came when the team compared the fitness of four strains -- two EWs and two ELs -- and found that while all four strains had significantly higher fitness than the ancestral strain, the ELs appeared more fit than the EWs. Comparing the four strains directly confirmed the result: The two EW strains were at a significant disadvantage to the ELs. If these strains had not accumulated any more mutations, the researchers estimated the EWs would have gone extinct in just 350 additional generations.But it wasn't just evolutionary luck that allowed the EWs to prevail over the ELs. When the researchers "replayed" evolution by culturing 10 replicate populations for each of the four strains for 883 generations, the EW populations almost always came out on top, acquiring more beneficial mutations that allowed them to overcome their fitness disadvantage to the ELs. The results suggested that the EWs, while initially at a disadvantage, prevailed in the long-term because they were more likely to acquire more beneficial mutations. In other words, the EWs had greater evolvability. "It's exciting to see some evidence that this sort of thing, which everyone has been speculating about," Desai said. "The question is how common are these sort of interactions."The large population sizes used in this study reduced competition between strains, allowing the less fit EWs to stick around long enough to accumulate the mutations that would eventually give them a fitness advantage. And the laboratory conditions in which the bacteria were held were unnaturally constant. Resource availability and environmental variation could affect the likelihood that evolution will select for strains on the basis of their evolvability."Whether natural populations can really select on those differences in evolvability will depend on a lot of things that we don't understand," said Desai. "But the point is that such differences in evolvability exist."The researchers didn't find any changes in overall mutation rate among the strains, but proposed that the differences in evolvability may be due to interactions between the mutations that existed at the start of the replay experiments and those that later evolved. A mutation called topA1 in the EL strains, for example, which affects an enzyme involved in winding and unwinding DNA, appeared to dampen the fitness advantage of a subsequent mutation in the spoT gene, which encodes a global regulator of gene expression. While the spoT mutation conferred a significant fitness advantage to the EW strains that lacked the topA1 mutation, it had no significant effect on the EL strain, possibly due to the changes in DNA supercoiling that resulted from the EL mutation in topA."It's a pretty exciting result," said evolutionary biologist linkurl:Paul Turner;http://f1000.com/thefaculty/member/2127916453245250 of Yale University, who did not participate in the study. "Evolutionary biology is not generally known as a predictive science," he said, noting the exception that scientists have used historical data on the success of flu virus lineages to predict which strains to target with the vaccine for the following year. "Maybe a study like this helps us do this in a more generalized way."R.J. Woods et al., "Second-order selection for evolvability in a large Escherichia coli population," Science, 331: 1433-6, 2011.
**__Related stories:__*** linkurl:Should evolutionary theory evolve?;http://www.the-scientist.com/2010/1/1/24/1/
[January 2010]*linkurl:Darwinian time;http://www.the-scientist.com/2009/01/1/26/1/
[January 2009]

**__Related F1000 Evaluations:__***linkurl:Plasticity of animal genome architecture unmasked by rapid evolution of a pelagic tunicate;http://f1000.com/9026958?key=953n4hb8794sbf2
F. Denoeud et al., Science 330:1381-5, 2010. Evaluated by Gemma Richards and Bernie Degnan, University of Queensland.*linkurl:Evidence that adaptation in Drosophila is not limited by mutation at single sites;http://f1000.com/3836964?key=4pmy3v940vx9tr6
T. Karasov et al., PLoS Genet., 6:e1000924, 2010. Evaluated by Devin Scannell and Michael Eisen, Lawrence Berkeley National Laboratory.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform